Watch LUNG. Know when insiders buy.
One email the day a filing lands. Free.
Work order
45
WATCH · insiders 41, shorts 48
Insiders, 90 days
−$177K
net selling · 0 buys, 14 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $94.9MP/E —DIV YIELD —FCF YIELD -32.31%REV TTM $87.4M −3.4%NET INCOME −$48.1MNET CASH $18.3M52W 1.17 – 2.60SEC XBRL · TTM TO Invalid Date
Insider trading
−$177K
Net, 90 days
0 / 14
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1 | Sep 3 | Radhakrishnan Srikanth · Chief Science & Techn. Officer | Sell | 5,863 | $2.26 | $13K |
| Sep 1 | Sep 3 | Radhakrishnan Srikanth · Chief Science & Techn. Officer | Sell | 3,618 | $2.26 | $8K |
| Sep 1 | Sep 3 | Radhakrishnan Srikanth · Chief Science & Techn. Officer | Sell | 2,121 | $2.26 | $5K |
| Sep 1 | Sep 3 | Radhakrishnan Srikanth · Chief Science & Techn. Officer | Sell | 2,643 | $2.26 | $6K |
| Sep 1 | Sep 3 | Rose Geoffrey Beran · Chief Commercial Officer | Sell | 1,746 | $2.26 | $4K |
| Sep 1 | Sep 3 | Rose Geoffrey Beran · Chief Commercial Officer | Sell | 1,530 | $2.26 | $3K |
| Sep 1 | Sep 3 | Rose Geoffrey Beran · Chief Commercial Officer | Sell | 2,390 | $2.26 | $5K |
| Sep 1 | Sep 3 | Rose Geoffrey Beran · Chief Commercial Officer | Sell | 2,213 | $2.26 | $5K |
| Sep 1 | Sep 3 | Lehman David Aaron · General Counsel | Sell | 4,827 | $2.26 | $11K |
| Sep 1 | Sep 3 | Lehman David Aaron · General Counsel | Sell | 3,476 | $2.26 | $8K |
| Sep 1 | Sep 3 | Lehman David Aaron · General Counsel | Sell | 2,224 | $2.26 | $5K |
| Sep 1 | Sep 3 | Lehman David Aaron · General Counsel | Sell | 3,807 | $2.26 | $9K |
| Sep 1 | Sep 3 | French Glendon E. III · President and CEO | Sell | 37,784 | $2.26 | $85K |
| Sep 1 | Sep 3 | French Glendon E. III · President and CEO | Sell | 4,098 | $2.26 | $9K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.